Literature DB >> 31592245

Stool-Based Tests Vs Screening Colonoscopy for the Detection of Colorectal Cancer.

David A Ahlquist1.   

Abstract

Entities:  

Year:  2019        PMID： 31592245      PMCID： PMC6771036     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  10 in total

Review 1.  Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis.

Authors:  Lukejohn W Day; Annette Kwon; John M Inadomi; Louise C Walter; Ma Somsouk
Journal:  Gastrointest Endosc       Date:  2011-10       Impact factor: 9.427

2.  The Case for a Multitarget Stool DNA Test: A Closer Look at the Cost Effectiveness Model.

Authors:  Steven H Itzkowitz; David A Ahlquist
Journal:  Gastroenterology       Date:  2017-04-03       Impact factor: 22.682

3.  Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.

Authors:  Andrew M D Wolf; Elizabeth T H Fontham; Timothy R Church; Christopher R Flowers; Carmen E Guerra; Samuel J LaMonte; Ruth Etzioni; Matthew T McKenna; Kevin C Oeffinger; Ya-Chen Tina Shih; Louise C Walter; Kimberly S Andrews; Otis W Brawley; Durado Brooks; Stacey A Fedewa; Deana Manassaram-Baptiste; Rebecca L Siegel; Richard C Wender; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2018-05-30       Impact factor: 508.702

4.  Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening.

Authors:  David H Johnson; John B Kisiel; Kelli N Burger; Douglas W Mahoney; Mary E Devens; David A Ahlquist; Seth Sweetser
Journal:  Gastrointest Endosc       Date:  2016-11-21       Impact factor: 9.427

5.  Adherence to Competing Strategies for Colorectal Cancer Screening Over 3 Years.

Authors:  Peter S Liang; Chelle L Wheat; Anshu Abhat; Alison T Brenner; Angela Fagerlin; Rodney A Hayward; Jennifer P Thomas; Sandeep Vijan; John M Inadomi
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

6.  Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People.

Authors:  Diana G Redwood; Elvin D Asay; Ian D Blake; Pamela E Sacco; Claudia M Christensen; Frank D Sacco; James J Tiesinga; Mary E Devens; Steven R Alberts; Douglas W Mahoney; Tracy C Yab; Patrick H Foote; Thomas C Smyrk; Ellen M Provost; David A Ahlquist
Journal:  Mayo Clin Proc       Date:  2015-10-28       Impact factor: 7.616

7.  Adenoma detection rate and risk of colorectal cancer and death.

Authors:  Douglas A Corley; Christopher D Jensen; Amy R Marks; Wei K Zhao; Jeffrey K Lee; Chyke A Doubeni; Ann G Zauber; Jolanda de Boer; Bruce H Fireman; Joanne E Schottinger; Virginia P Quinn; Nirupa R Ghai; Theodore R Levin; Charles P Quesenberry
Journal:  N Engl J Med       Date:  2014-04-03       Impact factor: 91.245

8.  Multitarget stool DNA testing for colorectal-cancer screening.

Authors:  Thomas F Imperiale; David F Ransohoff; Steven H Itzkowitz; Theodore R Levin; Philip Lavin; Graham P Lidgard; David A Ahlquist; Barry M Berger
Journal:  N Engl J Med       Date:  2014-03-19       Impact factor: 91.245

9.  Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.

Authors:  Mark Prince; Lynn Lester; Rupal Chiniwala; Barry Berger
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

10.  Long-term colorectal-cancer incidence and mortality after lower endoscopy.

Authors:  Reiko Nishihara; Kana Wu; Paul Lochhead; Teppei Morikawa; Xiaoyun Liao; Zhi Rong Qian; Kentaro Inamura; Sun A Kim; Aya Kuchiba; Mai Yamauchi; Yu Imamura; Walter C Willett; Bernard A Rosner; Charles S Fuchs; Edward Giovannucci; Shuji Ogino; Andrew T Chan
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245
  10 in total
  1 in total

1.  Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population.

Authors:  Jordan J Karlitz; A Mark Fendrick; Jay Bhatt; Gloria D Coronado; Sushanth Jeyakumar; Nathaniel J Smith; Marcus Plescia; Durado Brooks; Paul Limburg; David Lieberman
Journal:  Popul Health Manag       Date:  2021-12-24       Impact factor: 2.290
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.